CV: CapsoVision Inc Price/Earnings to Growth Multiple

Patents for panoramic wireless endoscopy provide CapsoVision Inc (CV) with a sustainable advantage. The current PEG ratio reflects this trend, where the 0.00 mark indicates the asset's valuation level. Success is based on the delivery of capsule systems to hospitals, while operational reliability is guaranteed by the express delivery of fragile devices. This approach minimizes risks during expansion within the medical imaging sector.

CV: CapsoVision, Inc. Price/Earnings to Growth Ratio 07/03/2025 - 11/10/2026

Analytical breakdowns for CapsoVision Inc (CV)

- price and consensus price forecast:

Market Chart capsovision.com|CV - Analyst Consensus Forecast

- market capitalization information:

Market Valuation CapsoVision Medical|CV - Real Price to Acquire Entire Company

- book value of equity indicators:

Accounting Value of a Share CapsoVision Inc|CV - Company Book Value|Market Cap to Net Assets Ratio capsovision.com|CV - Company Total Assets

- business debt structure and liquidity details:

- earnings and valuation multiples information:

CV - Company Net Income|Expected Profit CapsoVision Inc|CV - Price to Earnings Ratio|Future Price to Earnings Multiple capsovision.com|CV - PEG Multiple|Company Value to EBITDA CapsoVision Medical|CV - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year CapsoVision Inc|CV - Net earnings per share for the last 12 months|Quarterly EPS earnings growth capsovision.com|CV - Earnings growth in current year|Consensus forecast of earnings per share growth for next year CapsoVision Inc

General company analysis:CV, CapsoVision, Inc.

Mass-produced product of CapsoVision, Inc.

The PEG ratio compares the current P/E multiple with earnings growth rates, making it possible to identify an asset's undervaluation relative to its expansion. By analyzing the growth-adjusted P/E value, an investor assesses the resilience of the capitalization to macro cycles, which is particularly relevant for CapsoVision Inc (CV) due to the low demand elasticity for its unique panoramic endoscopy systems and strong pricing power within the niche.

Competing companies